Please sign in to follow a disease.
Sphingolipidosis
MONDO:0019255An inherited metabolic disorder that affects the lysosomal degradation of the spinhgolipids. Representative examples include Gaucher disease, Tay-Sachs disease, and Niemann-Pick disease.
166 clinical trials for this condition and its sub-types, 6 tagged with Sphingolipidosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Sphingolipidosis
-
Fabry disease 64 trials
-
Gaucher disease 46 trials
5 sub-types
- Gaucher disease type I 12 trials
- Gaucher disease type III 12 trials
- Gaucher disease type II 5 trials
- Gaucher disease perinatal lethal 0 trials
- Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome 0 trials
-
Gangliosidosis 3 trials · 24 incl. sub-types
2 sub-types
- GM2 gangliosidosis 14 trials · 19 incl. sub-types Sub-types →
- GM1 gangliosidosis 12 trials Sub-types →
-
Niemann-Pick disease 10 trials · 22 incl. sub-types
4 sub-types
- Niemann-Pick disease type C 12 trials · 13 incl. sub-types Sub-types →
- Acid sphingomyelinase deficiency 7 trials · 10 incl. sub-types Sub-types →
- Niemann-Pick disease type E 0 trials
- Chronic neurovisceral acid sphingomyelinase deficiency 0 trials
-
Metachromatic leukodystrophy 20 trials
2 sub-types
- Metachromatic leukodystrophy, juvenile form 2 trials · 4 incl. sub-types Sub-types →
- Metachromatic leukodystrophy due to saposin B deficiency 0 trials
-
Krabbe disease 15 trials
3 sub-types
- Infantile Krabbe disease 2 trials
- Adult Krabbe disease 0 trials
- Late-infantile/juvenile Krabbe disease 0 trials
-
Mucosulfatidosis 4 trials
-
ASAH1-related sphingolipidosis 0 trials · 1 incl. sub-types
2 sub-types
-
PSAP-related sphingolipidosis 0 trials · 1 incl. sub-types
4 sub-types
-
Sea-blue histiocyte syndrome 0 trials
Most studied deeper sub-types
-
New stem cell approach aims to tame rare genetic diseases
Disease control OngoingThis study tests a stem cell transplant method for people with inherited metabolic disorders and severe osteopetrosis. The goal is to get the donor cells to take hold while keeping side effects low. Participants receive chemotherapy drugs before the transplant to prepare their bo…
Phase 2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Gene therapy boost for krabbe patients after transplant
Disease control OngoingThis early-phase trial tests a single infusion of a gene therapy called FBX-101 in 9 people with Krabbe disease who have already received a stem cell transplant. The therapy uses a harmless virus to deliver a working copy of the GALC gene, aiming to improve motor function and saf…
Phase 1/2 • Sponsor: Forge Biologics, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC